Active ingredients: buprenorphine
What it is used for
TEMGESIC sublingual tablets are indicated for the short-term (not more than one week) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. TEMGESIC is not recommended for use in children. TEMGESIC does not have an approved role in opioid dependence rehabilitation programmes.
How to take it
The way to take this medicine is: Sublingual. This medicine is placed under the tongue.
- Store below 30 degrees Celsius
- Protect from Light
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
White, circular, biconvex tablet, debossed on one side with "L".
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems